Clinical Trial Update: Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating IPS101A for safety, efficacy, and pharmacokinetics in Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IPS101A (IPS101A)

Snippet

Sponsor: Innopeutics Corporation | Conditions: Parkinson Disease, Parkinson's Disease | Phase 1 | Status: RECRUITING